把握创新驱动型企业布局机会，医疗ETF（159828）涨超1.3%，今日净流入近1000万份

Core Viewpoint - The medical ETF (159865) has seen a net inflow of 9 million units, indicating strong demand for medical assets. The "14th Five-Year Plan" emphasizes support for innovation in medical devices, suggesting a potential release of demand in areas like emergency equipment and in vitro diagnostics. The current adjustment in the sector is primarily influenced by market sentiment, with a focus on performance certainty as third-quarter reports are released. Companies should leverage policy benefits and industry upgrades to identify opportunities in innovation-driven enterprises [1]. Group 1 - The medical ETF (159828) tracks the CSI Medical Index (399989), which selects listed companies in the medical and pharmaceutical retail sectors from the Shanghai and Shenzhen markets. This index primarily covers medical devices, medical services, and medical R&D outsourcing, reflecting the overall performance of related listed companies [1]. - The index components are skewed towards small and mid-cap stocks, which exhibit higher growth potential and volatility characteristics [1].